Search hospitals > Arizona > Scottsdale
HonorHealth
Claim this profileScottsdale, Arizona 85258
Global Leader in Solid Tumors
Global Leader in Cancer
Conducts research for Pancreatic Cancer
Conducts research for Lung Cancer
Conducts research for Ovarian Cancer
141 reported clinical trials
17 medical researchers
Summary
HonorHealth is a medical facility located in Scottsdale, Arizona. This center is recognized for care of Solid Tumors, Cancer, Pancreatic Cancer, Lung Cancer, Ovarian Cancer and other specialties. HonorHealth is involved with conducting 141 clinical trials across 319 conditions. There are 17 research doctors associated with this hospital, such as Michael S Gordon, MD, Sunil Sharma, Erkut Borazanci, MD, and Justin Moser, MD.Area of expertise
1Solid Tumors
Global LeaderStage IV
BRAF positive
Stage III
2Cancer
Global LeaderStage IV
HER2 negative
Beta-catenin positive
Top PIs
Michael S Gordon, MDHonor Health Research Institute3 years of reported clinical research
Studies Solid Tumors
Studies Cancer
18 reported clinical trials
26 drugs studied
Sunil SharmaHonorHealth Research Institute1 year of reported clinical research
Studies Colorectal Cancer
Studies Cancer
16 reported clinical trials
34 drugs studied
Erkut Borazanci, MDHonor Health Research Institute2 years of reported clinical research
Expert in Pancreatic Cancer
Studies Solid Tumors
16 reported clinical trials
27 drugs studied
Justin Moser, MDHonorHealth Research Institute3 years of reported clinical research
Studies Solid Tumors
Studies Melanoma
16 reported clinical trials
32 drugs studied
Clinical Trials running at HonorHealth
Pancreatic Cancer
Ovarian Cancer
Heart Failure
Prostate Cancer
Solid Tumors
Cancer
Breast Cancer
Lung Cancer
Atrial Fibrillation
Lymphoma
Exosome-Based Detection
for Pancreatic Cancer
This study aims to prospective validate an exosome-based miRNA signature for noninvasive and early detection of pancreatic ductal adenocarcinoma.
Recruiting1 award N/A3 criteria
FOG-001
for Cancer
This trial is testing FOG-001, a new medicine, to see if it is safe and effective for patients with advanced or spreading solid tumors. FOG-001 works by blocking certain proteins to stop cancer cells from growing.
Recruiting1 award Phase 1 & 28 criteria
LY4170156
for Breast Cancer
The purpose of this study is to find out whether the study drug, LY4170156, is safe, tolerable and effective in participants with advanced solid tumors. The study is conducted in two parts - phase Ia (dose-escalation, dose-optimization) and phase Ib (dose-expansion). The study will last up to approximately 4 years.
Recruiting1 award Phase 11 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at HonorHealth?
HonorHealth is a medical facility located in Scottsdale, Arizona. This center is recognized for care of Solid Tumors, Cancer, Pancreatic Cancer, Lung Cancer, Ovarian Cancer and other specialties. HonorHealth is involved with conducting 141 clinical trials across 319 conditions. There are 17 research doctors associated with this hospital, such as Michael S Gordon, MD, Sunil Sharma, Erkut Borazanci, MD, and Justin Moser, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.